A Phase I Trial of a Guadecitabine (SGI-110) and Irinotecan in Metastatic Colorectal Cancer Patients Previously Exposed to Irinotecan

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-18-0421 ◽

2018 ◽

Vol 24 (24) ◽

pp. 6160-6167 ◽

Author(s):

Valerie Lee ◽

Judy Wang ◽

Marianna Zahurak ◽

Elske Gootjes ◽

Henk M. Verheul ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase I ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Phase I Trial ◽

Colorectal Cancer Patients

Download Full-text

A phase I and pharmacokinetic study of irinotecan given as a 7 days continuous infusion in metastatic colorectal cancer patients pretreated with 5-FU or raltitrexed

European Journal of Cancer ◽

10.1016/s0959-8049(01)81579-3 ◽

2001 ◽

Vol 37 ◽

pp. S294-S295

Author(s):

G. Masi ◽

A. Di Paolo ◽

G. Allegrini ◽

S. Cupini ◽

C. Galli ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase I ◽

Metastatic Colorectal Cancer ◽

Continuous Infusion ◽

Cancer Patients ◽

Pharmacokinetic Study ◽

Colorectal Cancer Patients

Download Full-text

A Phase I and Pharmacokinetic Study of Irinotecan Given as a 7-Day Continuous Infusion in Metastatic Colorectal Cancer Patients Pretreated with 5-Fluorouracil or Raltitrexed

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-1585-3 ◽

2004 ◽

Vol 10 (5) ◽

pp. 1657-1663 ◽

Author(s):

Gianluca Masi ◽

Alfredo Falcone ◽

Antonello Di Paolo ◽

Giacomo Allegrini ◽

Romano Danesi ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase I ◽

Metastatic Colorectal Cancer ◽

Continuous Infusion ◽

Cancer Patients ◽

Pharmacokinetic Study ◽

Colorectal Cancer Patients

Download Full-text

In vitro preclinical study results for a phase I adoptive immunotherapy trial using cetuximab with allogeneic NK cells in KRAS oncogene-mutated metastatic colorectal cancer patients.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e14057 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e14057-e14057

Author(s):

F. Re ◽

E. Todisco ◽

D. Genovese ◽

I. Turin ◽

L. Rimassa ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase I ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Adoptive Immunotherapy ◽

Preclinical Study ◽

Study Results ◽

Immunotherapy Trial ◽

Colorectal Cancer Patients

Download Full-text

Double 5-FU modulation with folinic acid and recombinant alfa2b-Interferon : a phase I–II study in metastatic colorectal cancer patients

Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy ◽

10.1007/978-2-8178-0782-9_56 ◽

1991 ◽

pp. 227-230

Author(s):

I. Brunetti ◽

A. Falcone ◽

A. Vigani ◽

P. Giannessi ◽

C. Cianci ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase I ◽

Metastatic Colorectal Cancer ◽

Folinic Acid ◽

Cancer Patients ◽

Colorectal Cancer Patients

Download Full-text

SPICE, a phase I study of enadenotucirev in combination with nivolumab in tumours of epithelial origin: Analysis of the metastatic colorectal cancer patients in the dose escalation phase

Annals of Oncology ◽

10.1093/annonc/mdz246.089 ◽

2019 ◽

Vol 30 ◽

pp. v231

Author(s):

M.G. Fakih ◽

D. Wang ◽

W. Harb ◽

L. Rosen ◽

D. Mahadevan ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase I ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Dose Escalation ◽

Phase I Study ◽

Epithelial Origin ◽

Colorectal Cancer Patients ◽

Origin Analysis

Download Full-text

PD-013 Final survival results of a multicenter phase I/II study of TAS-102 with bevacizumab for metastatic colorectal cancer patients refractory to standard therapies (C-TASK FORCE)

Annals of Oncology ◽

10.1093/annonc/mdw200.13 ◽

2016 ◽

Vol 27 ◽

pp. ii106

Author(s):

T. Yoshino ◽

Y. Kuboki ◽

T. Nishina ◽

E. Shinozaki ◽

K. Yamazaki ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase I ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Multicenter Phase ◽

Final Survival ◽

Colorectal Cancer Patients

Download Full-text

A phase I/II, open-label, randomised study of nintedanib plus mFOLFOX6 versus bevacizumab plus mFOLFOX6 in first-line metastatic colorectal cancer patients

Annals of Oncology ◽

10.1093/annonc/mdv286 ◽

2015 ◽

Vol 26 (10) ◽

pp. 2085-2091 ◽

Author(s):

E. Van Cutsem ◽

H. Prenen ◽

G. D'Haens ◽

J. Bennouna ◽

A. Carrato ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase I ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Randomised Study ◽

Colorectal Cancer Patients

Download Full-text

A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy

Investigational New Drugs ◽

10.1007/s10637-011-9683-8 ◽

2011 ◽

Vol 30 (4) ◽

pp. 1501-1510 ◽

Author(s):

Sang Joon Shin ◽

Minkyu Jung ◽

Hei-Cheul Jeung ◽

Hye Ryun Kim ◽

Sun Young Rha ◽

...

Keyword(s):

Colorectal Cancer ◽

Tyrosine Kinase ◽

Phase I ◽

Metastatic Colorectal Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Pharmacokinetic Study ◽

Kinase Inhibitor ◽

Previously Treated ◽

Colorectal Cancer Patients

Download Full-text

PD-8 Regorafenib with TAS-102 in metastatic colorectal cancer patients who progressed after at least two standard therapies: Efficacy and safety results of a multicenter phase I study (REMETY)

Annals of Oncology ◽

10.1016/j.annonc.2020.04.464 ◽

2020 ◽

Vol 31 ◽

pp. S214

Author(s):

M. Moehler ◽

A. Stein ◽

J. Trojan ◽

J. Marquardt ◽

J. Quidde ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase I ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Phase I Study ◽

Efficacy And Safety ◽

Multicenter Phase ◽

Colorectal Cancer Patients

Download Full-text

Faculty Opinions recommendation of Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726943980.793538773 ◽

2017 ◽

Author(s):

Noelle LoConte ◽

Kieran Sahasrabudhe

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Phase Iii ◽

Phase Iii Study ◽

Colorectal Cancer Patients ◽

Line Chemotherapy

Download Full-text